Literature DB >> 30503706

A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence.

Bin Lu1, Olaf Klingbeil1, Yusuke Tarumoto1, Tim D D Somerville1, Yu-Han Huang1, Yiliang Wei1, Dorothy C Wai2, Jason K K Low2, Joseph P Milazzo1, Xiaoli S Wu1, Zhendong Cao3, Xiaomei Yan4, Osama E Demerdash1, Gang Huang4, Joel P Mackay2, Justin B Kinney1, Junwei Shi5, Christopher R Vakoc6.   

Abstract

The Mixed Lineage Leukemia gene (MLL) is altered in leukemia by chromosomal translocations to produce oncoproteins composed of the MLL N-terminus fused to the C-terminus of a partner protein. Here, we used domain-focused CRISPR screening to identify ZFP64 as an essential transcription factor in MLL-rearranged leukemia. We show that the critical function of ZFP64 in leukemia is to maintain MLL expression via binding to the MLL promoter, which is the most enriched location of ZFP64 occupancy in the human genome. The specificity of ZFP64 for MLL is accounted for by an exceptional density of ZFP64 motifs embedded within the MLL promoter. These findings demonstrate how a sequence anomaly of an oncogene promoter can impose a transcriptional addiction in cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR screen; MLL; ZFP64; addiction; leukemia; motif; oncogene; promoter

Mesh:

Substances:

Year:  2018        PMID: 30503706      PMCID: PMC6554023          DOI: 10.1016/j.ccell.2018.10.015

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   38.585


  60 in total

1.  Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.

Authors:  Matthew G Guenther; Lee N Lawton; Tatiana Rozovskaia; Garrett M Frampton; Stuart S Levine; Thomas L Volkert; Carlo M Croce; Tatsuya Nakamura; Eli Canaani; Richard A Young
Journal:  Genes Dev       Date:  2008-12-15       Impact factor: 11.361

Review 2.  The Human Transcription Factors.

Authors:  Samuel A Lambert; Arttu Jolma; Laura F Campitelli; Pratyush K Das; Yimeng Yin; Mihai Albu; Xiaoting Chen; Jussi Taipale; Timothy R Hughes; Matthew T Weirauch
Journal:  Cell       Date:  2018-02-08       Impact factor: 41.582

3.  PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway.

Authors:  J Zhou; J Wu; B Li; D Liu; J Yu; X Yan; S Zheng; J Wang; L Zhang; L Zhang; F He; Q Li; A Chen; Y Zhang; X Zhao; Y Guan; X Zhao; J Yan; J Ni; M A Nobrega; B Löwenberg; R Delwel; P J M Valk; A Kumar; L Xie; D G Tenen; G Huang; Q-F Wang
Journal:  Leukemia       Date:  2013-12-26       Impact factor: 11.528

4.  Zinc finger protein 64 promotes Toll-like receptor-triggered proinflammatory and type I interferon production in macrophages by enhancing p65 subunit activation.

Authors:  Chunmei Wang; Xingguang Liu; Yin Liu; Qian Zhang; Zhenyu Yao; Bo Huang; Peng Zhang; Nan Li; Xuetao Cao
Journal:  J Biol Chem       Date:  2013-07-15       Impact factor: 5.157

5.  MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.

Authors:  Yufei Chen; Konstantinos Anastassiadis; Andrea Kranz; A Francis Stewart; Kathrin Arndt; Claudia Waskow; Akihiko Yokoyama; Kenneth Jones; Tobias Neff; Yoo Lee; Patricia Ernst
Journal:  Cancer Cell       Date:  2017-06-12       Impact factor: 31.743

6.  MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.

Authors:  Austin T Thiel; Peter Blessington; Tao Zou; Danielle Feather; Xinjiang Wu; Jizhou Yan; Hui Zhang; Zuguo Liu; Patricia Ernst; Gary A Koretzky; Xianxin Hua
Journal:  Cancer Cell       Date:  2010-02-17       Impact factor: 31.743

Review 7.  MLL translocations, histone modifications and leukaemia stem-cell development.

Authors:  Andrei V Krivtsov; Scott A Armstrong
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

8.  Cancer. Addiction to oncogenes--the Achilles heal of cancer.

Authors:  I Bernard Weinstein
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

9.  Zfp64 participates in Notch signaling and regulates differentiation in mesenchymal cells.

Authors:  Kei Sakamoto; Yoshihiro Tamamura; Ken-ichi Katsube; Akira Yamaguchi
Journal:  J Cell Sci       Date:  2008-04-22       Impact factor: 5.285

10.  An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes.

Authors:  J Corral; I Lavenir; H Impey; A J Warren; A Forster; T A Larson; S Bell; A N McKenzie; G King; T H Rabbitts
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

View more
  19 in total

1.  EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma.

Authors:  Seamus Balinth; Matthew L Fisher; Yon Hwangbo; Caizhi Wu; Carlos Ballon; Xueqin Sun; Alea A Mills
Journal:  Oncogene       Date:  2022-07-21       Impact factor: 8.756

2.  An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML.

Authors:  Clément Larrue; Nastassja K Scheidegger; Shan Lin; Bo Kyung A Seong; Neekesh V Dharia; Miljan Kuljanin; Caroline S Wechsler; Guillaume Kugener; Amanda L Robichaud; Amy Saur Conway; Thelma Mashaka; Sarah Mouche; Biniam Adane; Jeremy A Ryan; Joseph D Mancias; Scott T Younger; Federica Piccioni; Lynn H Lee; Mark Wunderlich; Anthony Letai; Jérôme Tamburini; Kimberly Stegmaier
Journal:  Cancer Discov       Date:  2021-09-16       Impact factor: 38.272

3.  SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia.

Authors:  Yiliang Wei; Yu-Han Huang; Damianos S Skopelitis; Shruti V Iyer; Ana S H Costa; Zhaolin Yang; Melissa Kramer; Emmalee R Adelman; Olaf Klingbeil; Osama E Demerdash; Sofya A Polyanskaya; Kenneth Chang; Sara Goodwin; Emily Hodges; W Richard McCombie; Maria E Figueroa; Christopher R Vakoc
Journal:  Cancer Discov       Date:  2021-09-16       Impact factor: 38.272

4.  Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4.

Authors:  Soledad A Camolotto; Veronika K Belova; Luke Torre-Healy; Jeffery M Vahrenkamp; Kristofer C Berrett; Hannah Conway; Jill Shea; Chris Stubben; Richard Moffitt; Jason Gertz; Eric L Snyder
Journal:  Gut       Date:  2020-08-21       Impact factor: 23.059

5.  ZNF410 represses fetal globin by singular control of CHD4.

Authors:  Divya S Vinjamur; Qiuming Yao; Mitchel A Cole; Connor McGuckin; Chunyan Ren; Jing Zeng; Mir Hossain; Kevin Luk; Scot A Wolfe; Luca Pinello; Daniel E Bauer
Journal:  Nat Genet       Date:  2021-04-15       Impact factor: 38.330

6.  The human origin recognition complex is essential for pre-RC assembly, mitosis, and maintenance of nuclear structure.

Authors:  Hsiang-Chen Chou; Kuhulika Bhalla; Osama El Demerdesh; Olaf Klingbeil; Kaarina Hanington; Sergey Aganezov; Peter Andrews; Habeeb Alsudani; Kenneth Chang; Christopher R Vakoc; Michael C Schatz; W Richard McCombie; Bruce Stillman
Journal:  Elife       Date:  2021-02-01       Impact factor: 8.140

7.  Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.

Authors:  Sumiko Takao; Lauren Forbes; Masahiro Uni; Shuyuan Cheng; Jose Mario Bello Pineda; Yusuke Tarumoto; Paolo Cifani; Gerard Minuesa; Celine Chen; Michael G Kharas; Robert K Bradley; Christopher R Vakoc; Richard P Koche; Alex Kentsis
Journal:  Elife       Date:  2021-02-02       Impact factor: 8.713

8.  ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression.

Authors:  Xianjiang Lan; Ren Ren; Ruopeng Feng; Lana C Ly; Yemin Lan; Zhe Zhang; Nicholas Aboreden; Kunhua Qin; John R Horton; Jeremy D Grevet; Thiyagaraj Mayuranathan; Osheiza Abdulmalik; Cheryl A Keller; Belinda Giardine; Ross C Hardison; Merlin Crossley; Mitchell J Weiss; Xiaodong Cheng; Junwei Shi; Gerd A Blobel
Journal:  Mol Cell       Date:  2020-12-09       Impact factor: 19.328

Review 9.  Perturbing Enhancer Activity in Cancer Therapy.

Authors:  Feda H Hamdan; Steven A Johnsen
Journal:  Cancers (Basel)       Date:  2019-05-07       Impact factor: 6.639

10.  ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.

Authors:  Zhendong Cao; Krista A Budinich; Hua Huang; Diqiu Ren; Bin Lu; Zhen Zhang; Qingzhou Chen; Yeqiao Zhou; Yu-Han Huang; Fatemeh Alikarami; Molly C Kingsley; Alexandra K Lenard; Aoi Wakabayashi; Eugene Khandros; Will Bailis; Jun Qi; Martin P Carroll; Gerd A Blobel; Robert B Faryabi; Kathrin M Bernt; Shelley L Berger; Junwei Shi
Journal:  Mol Cell       Date:  2021-08-05       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.